A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix(®) PC1 System

SIMPLE SUMMARY: There is a great need to understand the cellular and molecular characteristics of cancer when access to the tumor is limited. Circulating tumor cells (CTCs) captured from the blood of cancer patients may serve as a surrogate source of tumor material. However, the only FDA-cleared CTC...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Evan N., Jayachandran, Gitanjali, Moore, Richard G., Cristofanilli, Massimo, Lang, Julie E., Khoury, Joseph D., Press, Michael F., Kim, Kyu Kwang, Khazan, Negar, Zhang, Qiang, Zhang, Youbin, Kaur, Pushpinder, Guzman, Roberta, Miller, Michael C., Reuben, James M., Ueno, Naoto T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656921/
https://www.ncbi.nlm.nih.gov/pubmed/36358657
http://dx.doi.org/10.3390/cancers14215238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656921/
https://www.ncbi.nlm.nih.gov/pubmed/36358657
http://dx.doi.org/10.3390/cancers14215238

Ejemplares similares